What is Irritable Bowel Syndrome?
 

Irritable Bowel Syndrome (IBS) is a common functional gastrointestinal (GI) disorder categorized as a disorder of gut-brain interaction. Unlike inflammatory bowel disease (IBD) or celiac disease, IBS does not cause structural damage, physical inflammation, ulcers, or an increased risk of colorectal cancer. Instead, it involves altered communication between the central nervous system and the enteric nervous system of the gut, leading to abnormal intestinal motility, heightened visceral sensitivity, and chronic abdominal pain paired with altered bowel habits.
 

Formal Diagnostic Criteria: Rome IV Standards
 

Adults: must experience recurrent abdominal pain, on average, at least 1 day per week in the last 3 months, with symptom onset occurring at least 6 months prior to diagnosis. The abdominal pain does not resolve with the resolution of constipation or diarrhea. Additionally, the abdominal pain must be associated with at least 2 of the following 3 features:
 

1. Related to defecation (either worsening or improving with a bowel movement).

2. Associated with a change in stool frequency (more frequent or less frequent bowel movements).

3. Associated with a change in stool form (appearance) (e.g., lumpy/hard or loose/watery).
    

IBS is clinically categorized into four distinct subtypes based on a patient's predominant stool consistency (evaluated using the Bristol Stool Form Scale):
 

• IBS with Constipation (IBS-C): Hard, lumpy, or infrequent stools predominate (x>25% hard/lumpy stools and x<25% loose/watery stools).

• IBS with Diarrhea (IBS-D): Loose, watery, or urgent stools predominate (x>25% loose/watery stools and <25% hard/lumpy stools).

• IBS with Mixed Bowel Habits (IBS-M): Alternating periods of both constipation and diarrhea (x>25% hard/lumpy stools and >25% loose/watery stools).

• IBS Unclassified (IBS-U): Patients who meet diagnostic criteria for IBS but whose stool consistency patterns do not neatly fit into C, D, or M.

Pediatrics (Ages 4-18):
 

Must include all of the following:
 

1. Abdominal pain at least 4 days per month.

2. Associated with one or more of the following:

   • Related to defecation.

   • Change in stool frequency.

   • Change in stool form/appearance.

3. The abdominal pain does not resolve with the resolution of constipation or diarrhea 

4. Symptoms cannot be fully explained by another medical condition after appropriate evaluation.

Differential Diagnoses

Functional Dyspepsia
 

Must include one or more bothersome symptoms at least 4 days per month:
 

• Postprandial fullness.

• Early satiety.

• Epigastric pain or burning not associated with defecation.

• No evidence of an organic disease process after appropriate medical evaluation.

Abdominal Migraine
 

Must include all of the following occurring at least twice:
 

• Paroxysmal episodes of intense, acute periumbilical, midline, or diffuse abdominal pain lasting 1 hour or more.

• Episodes are separated by weeks to months of normal health.

• Pain is incapacitating and interferes with daily activities.

• Stereotypical pattern for the individual.

• Accompanied by at least 2 associated symptoms: Anorexia, nausea, vomiting, headache, photophobia, or pallor.

• No evidence of an organic disease process after appropriate medical evaluation.

Functional Abdominal Pain – Not Otherwise Specified (FAP-NOS)
 

• Episodic or continuous abdominal pain that does not occur solely during physiological events (e.g., eating, menses).

• Insufficient criteria for IBS, functional dyspepsia, or abdominal migraine.

• No evidence of an organic disease process after appropriate medical evaluation.

Pathophysiology & Contributing Factors
 

While the exact root cause of IBS varies from person to person, several interconnected mechanisms drive symptoms:
 

• Gut-Brain Axis Dysregulation: Disrupted signaling between the brain and the digestive tract, causing normal gut contraction forces to be perceived as severe pain or cramping.

• Visceral Hypersensitivity: Extra-sensitive nerve endings in the intestinal walls that trigger pain responses even to normal gas, fluid, or stool volume.

• Altered Motility: Intestinal smooth muscle contracting too quickly (leading to diarrhea and spasms) or too slowly (leading to constipation and bloating).

• Post-Infectious IBS: Onset of chronic symptoms following a severe bout of acute bacterial or viral gastroenteritis.

• Gut Microbiome Dysbiosis & Permeability: Alterations in the diversity or balance of intestinal microflora, or mild mucosal immune activation.

​

"Alarm Symptoms" (Red Flags)
 

The presence of any of the following requires further diagnostic evaluation (such as a colonoscopy or blood work) to rule out structural organic diseases like inflammatory bowel disease (Crohn's or ulcerative colitis), celiac disease, or malignancy:
 

• Age of symptom onset > 50 years

• Unexplained, unintentional weight loss

• Gastrointestinal bleeding (rectal bleeding or blood in the stool)

• Nocturnal diarrhea (waking up at night to have a bowel movement)

• Fever or persistent severe abdominal pain

• Family history of colorectal cancer, celiac disease, or inflammatory bowel disease

Management & Treatment Strategies
 

• Dietary & Lifestyle Interventions:
   

  • Low-FODMAP Diet: A structured, 3-phase diet (Elimination, Reintroduction, Personalization) that restricts Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols—short-chain carbohydrates that ferment rapidly and draw water into the gut.

  • Soluble fiber 

  • Cognitive behavioral therapy, gut-directed hypnotherapy, and stress reduction
     

• Pharmacotherapy for IBS-C (Constipation-Predominant):
   

  • Laxatives and stool softeners

  • Fiber and hydration
     

• Pharmacotherapy for IBS-D (Diarrhea-Predominant):
   

  • Antidiarrheals: Loperamide (Imodium) for episodic diarrhea management.

  • Targeted Gut Therapies: Rifaximin (Xifaxan), a non-absorbable antibiotic used to treat bacterial overgrowth/dysbiosis; or eluxadoline (Viberzi), a mu-opioid receptor agonist that slows gut motility.

  • Bile Acid Sequestrants: Cholestyramine or colesevelam if bile acid diarrhea is a contributing factor.
     

• Centrally Acting Neuromodulators (For Pain & Hypersensitivity):
   

  • Tricyclic Antidepressants (TCAs) – e.g., low-dose amitriptyline: Highly effective at slowing transit time and dulling visceral pain signals in IBS-D.

  • Selective Serotonin Reuptake Inhibitors (SSRIs): Can help improve mood and motility, particularly in IBS-C with concurrent anxiety.

  • Antispasmodics: Medications like dicyclomine or hyoscyamine to relieve acute abdominal muscle cramping.